News
Even patients with cancer in remission at risk for severe COVID-19
January 26, 2021
Cancer patients, regardless of their age, and even if they are in remission, should be prioritized for vaccination against COVID-19.
![1]()
News
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
Upper GI bleeds in COVID-19 not related to increased mortality
December 9, 2020
A Spanish survey suggests upper GI bleeding and delays in endoscopies in COVID-19 patients have little effect on in-hospital mortality.
News
What to do when anticoagulation fails cancer patients
December 1, 2020
When it comes to “anticoagulation failure, we are entering an evidence free-zone.”
News
Liver injury linked to COVID-19–related coagulopathy
November 18, 2020
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.
![1]()
News
What happened to melanoma care during COVID-19 sequestration
November 11, 2020
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
News
FIT unfit for inpatient, emergency settings
November 5, 2020
The inappropriate use of FIT in these settings had no positive effect on clinical decision-making.
![1]()
Article
Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate
October 20, 2020
Patients younger than 70 years, without relapsed/refractory lymphoma had an 88% 30-day overall survival, comparable with the general population.
![1]()
News
INR fails to predict bleeding in patients with cirrhosis
October 6, 2020
The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.
News
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate
September 16, 2020
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments during the COVID-19 pandemic, although more research is needed and shared decision making is warranted.
